previously, clinical trials on GLP-one drugs have revealed their Advantages being a secondary prevention tool for heart problems (CVD), that means they might reduce the likelihood of the heart attack or stroke in https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/